chromium-51 — LLMpedia

Contents

chromium-51

Introduction

Chromium-51 is a radioisotope historically employed in nuclear medicine, tracer studies, and industrial assays. It has been referenced in literature from institutions such as Brookhaven National Laboratory, Lawrence Berkeley National Laboratory, Mayo Clinic, Massachusetts General Hospital, and regulatory guidance from the U.S. Nuclear Regulatory Commission. Researchers at organizations including World Health Organization, International Atomic Energy Agency, American Chemical Society, Royal Society, and British Medical Journal have documented its uses and safety profile.

Chromium-51 decays primarily by electron capture to form vanadium-51, with a half-life measured at approximately 27.7 days; these values are recorded in databases maintained by National Institute of Standards and Technology, International Atomic Energy Agency, European Organization for Nuclear Research, Los Alamos National Laboratory, and Oak Ridge National Laboratory. Its nuclear spin and magnetic moment have been studied in experiments at facilities such as CERN, Argonne National Laboratory, Rutherford Appleton Laboratory, Institut Laue–Langevin, and Kurchatov Institute. Spectroscopic data and gamma emissions used for detection appear in compilations from National Physical Laboratory, American Nuclear Society, Royal Institution, and the IEEE. Nuclear reaction cross sections relevant to production routes are tabulated by collaborations including ENDF/B, TENDL, JEFF, IAEA CRP, and analysis groups at Lawrence Livermore National Laboratory.

Production routes for chromium-51 typically use neutron irradiation of stable chromium targets in research or power reactors such as High Flux Isotope Reactor, European High Flux Reactor, BR2 Reactor, HANARO, and training reactors at MIT. Alternative production via charged-particle reactions in cyclotrons has been explored at centers like TRIUMF, Paul Scherrer Institute, National Superconducting Cyclotron Laboratory, Institute for Nuclear Research (INR) and industrial cyclotrons operated by Siemens, GE Healthcare, and university laboratories. Isotopic enrichment and target fabrication involve suppliers and facilities including Atomic Energy of Canada Limited, Areva, Rosatom, National Research Council (Canada), and university isotope programs at University of Tokyo and University of Manchester.

Medical uses historically include red blood cell labeling for blood volume studies, gastrointestinal bleeding localization, and erythrocyte survival assays performed in clinics such as Johns Hopkins Hospital, Cleveland Clinic, Stanford Hospital, UCLA Medical Center, and specialized units at Royal Free Hospital. In hematology and transfusion research, protocols from American Red Cross, British Blood Transfusion Service, European Society of Radiology, and Society of Nuclear Medicine and Molecular Imaging referenced chromium-51 assays. Industrial and scientific tracer applications were carried out in environmental monitoring by agencies like Environmental Protection Agency, Department of Energy, National Oceanic and Atmospheric Administration, United Nations Environment Programme, and in metallurgical studies at Nippon Steel, ThyssenKrupp, and ArcelorMittal. Research groups at University of Cambridge, Caltech, Princeton University, ETH Zurich, and Max Planck Society used chromium-51 in cellular labeling, membrane transport studies, and receptor assays.

Guidance on safe handling and radiological protection is provided by regulatory bodies and professional organizations including International Commission on Radiological Protection, U.S. Nuclear Regulatory Commission, Health and Safety Executive, Occupational Safety and Health Administration, Centers for Disease Control and Prevention, and European Medicines Agency. Dosimetry models and biokinetic behavior are discussed in publications from National Council on Radiation Protection and Measurements, International Atomic Energy Agency, World Health Organization, Public Health England, and research units at Karolinska Institutet. Incident response, contamination control, and waste management practices have been implemented by institutions such as Fukushima Daiichi Nuclear Power Plant response teams, Three Mile Island cleanup groups, and university radiation safety offices at Yale University and Columbia University. Occupational exposure limits, monitoring protocols, and personal protective equipment standards reference guidance from American National Standards Institute and International Organization for Standardization.

Early nuclear chemistry and radiochemistry work that characterized chromium radioisotopes involved laboratories connected to figures and events like Manhattan Project, Enrico Fermi, Otto Hahn, Marie Curie, Ernest Lawrence, and institutions such as Los Alamos National Laboratory and University of Göttingen. Clinical adoption and methodological refinements were reported in journals tied to New England Journal of Medicine, The Lancet, Nature, Science, and specialty periodicals of British Medical Journal and Journal of Nuclear Medicine. Later methodological comparisons and meta-analyses have been conducted by collaborations among Cochrane Collaboration, World Health Organization, European Medicines Agency, and academic consortia at Imperial College London and Johns Hopkins University, influencing phased reductions in routine clinical use as alternative isotopes and non-radioactive assays developed at centers like Memorial Sloan Kettering Cancer Center and Karolinska Institutet.

Category:Radioisotopes